Skip to main content
2025 IDWeek Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Session Icons
Live Streamed
Live Streamed
On Demand
On Demand

Kelly Dooley, MD PhD MPH

Director, Division of Infectious Diseases
Vanderbilt University Medical Center

Kelly E. Dooley, MD, PhD, MPH, is Professor and the Addison B. Scoville, Jr., Chair in Medicine and the Director of the Division of Infectious Diseases at Vanderbilt University Medical Center in Nashville, TN, USA. She is a clinical pharmacologist and infectious diseases physician. She earned her MD from Duke University, her MPH from the University of North Carolina at Chapel Hill, and PhD at the Johns Hopkins Bloomberg School of Public Health and completed her clinical pharmacology and infectious diseases fellowships at Johns Hopkins University School of Medicine.
Her research focuses on tuberculosis (TB) and HIV therapeutics. She is a lead investigator for trials of therapeutics for drug-sensitive and drug-resistant TB, TB-HIV, and pediatric TB meningitis. She holds leadership positions within the NIH’s Advancing Clinical Therapeutics Globally (ACTG) and CDC’s Tuberculosis Trials Consortium (TBTC) networks. She serves as a consultant to World Health Organization on TB and HIV therapeutics. She has a special interest in ensuring that novel therapeutics for TB are available to all, including priority populations such as children, people with HIV, and pregnant women.

Disclosure(s): No financial relationships to disclose.

Presentation(s):